The theranostic PSMA ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry, and first evaluation of tumor lesions - Afshar-Oromieh, Ali; Kratochwil, Clemens; Giesel, Frederik L.; Mier, Walter; Haberkorn, Uwe (Journal of nuclear medicine, 2015)
Gesehen am 22.09.2016